“…Eight of the 16 studies included in the meta-analysis were blinded randomized controlled trials, CEBM Level I, 32,34,36,[38][39][40]42,43 1 study was a nonblinded randomized controlled trial, CEBM Level II, 41 and the remaining 7 studies were case-controlled trials, CEBM Level III 1,3,23,24,33,35,37 (►Table 1). Sample sizes ranged from 24 to 373 patients receiving unilateral TKAs, a total of 2,610 patients (1,339 IA-TXA and 1,271 placebo) were enrolled in the 16 studies.…”